Serina Therapeutics, Inc. SER
SER
Serina Therapeutics, Inc. GNTA
Genenta Science S.p.A. SKYE
Skye Bioscience, Inc. JUNS
Jupiter Neurosciences, Inc. ALGS
Aligos Therapeutics, Inc. BRNS
Barinthus Biotherapeutics plc INMB
INmune Bio, Inc. XFOR
X4 Pharmaceuticals, Inc. TELO
Telomir Pharmaceuticals, Inc. Common Stock GRCE
Grace Therapeutics, Inc.
Serina Therapeutics, Inc. GNTA
Genenta Science S.p.A. SKYE
Skye Bioscience, Inc. JUNS
Jupiter Neurosciences, Inc. ALGS
Aligos Therapeutics, Inc. BRNS
Barinthus Biotherapeutics plc INMB
INmune Bio, Inc. XFOR
X4 Pharmaceuticals, Inc. TELO
Telomir Pharmaceuticals, Inc. Common Stock GRCE
Grace Therapeutics, Inc.
Performance
| Periode | SER | GNTA | SKYE | JUNS | ALGS | BRNS | INMB | XFOR | TELO | GRCE |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -48.88 % | -52.61 % | -56.94 % | -0.90 % | 41.46 % | -12.14 % | -71.32 % | 34.83 % | -19.89 % | 13.33 % |
| YTD | -46.08 % | -67.99 % | -67.37 % | -89.51 % | -73.18 % | -40.40 % | -62.88 % | -84.04 % | -65.36 % | -15.00 % |
| 1Y | -50.27 % | -72.95 % | -67.48 % | -89.87 % | -72.15 % | -27.55 % | -58.60 % | -80.24 % | -68.94 % | -16.26 % |
| 3Y | -86.72 % | -74.83 % | -71.38 % | -79.96 % | -57.70 % | -65.79 % | -75.30 % | -82.61 % | -79.86 % | 12.96 % |
| 5Y | -95.28 % | -86.82 % | -91.73 % | -79.96 % | -98.40 % | -94.76 % | -82.95 % | -98.13 % | -79.86 % | 12.96 % |
| 10Y | -97.16 % | -86.82 % | -99.47 % | -79.96 % | -97.12 % | -94.76 % | -77.10 % | -99.86 % | -79.86 % | 12.96 % |
| From the beginning | -97.16 % | -86.82 % | -99.96 % | -79.96 % | -97.12 % | -94.76 % | -77.10 % | -99.86 % | -79.86 % | 12.96 % |